Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 4

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(5)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05354778Not ApplicableRecruiting

HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

Role: lead

NCT05445037Not ApplicableRecruiting

Hemodynamic and Cerebral Effects Evaluation in Anesthesia

Role: lead

NCT04256096Phase 3Unknown

Randomization of Endovascular Treatment in Acute Ischemic Stroke in the Extended Time Window

Role: collaborator

NCT03655392Not ApplicableCompleted

Clinical, Functional and Inflammatory Evaluation in Asthmatic Patients After a Simple Short-Term Educational Program

Role: collaborator

NCT03311048Not ApplicableCompleted

Airway Inflammatory Profile Among Cleaning Workers From Different Workplaces

Role: collaborator

NCT02878837Phase 4Completed

Dexmedetomidine vs Midazolam for Intraoperative Sedation

Role: lead

NCT03128190Not ApplicableCompleted

Multi-center Trial of Goal-directed Fluid Management Based on Pulse Pressure Variation Monitoring

Role: lead

All 7 trials loaded